TABLE 4.
Cytokine | Serum level (pg/mL) | Spearman's rho | |||||||
---|---|---|---|---|---|---|---|---|---|
Reflux | Distention/bloating | Fecal soilage | Diarrhea | Social functioning | Emotional well‐being | Constipation | Total GIT score | ||
TNF‐α | 8.2 ± 3.1 | 0.41 * | −0.05 | −0.26 | −0.10 | −0.10 | −0.11 | −0.11 | −0.05 |
IL‐6 | 6.5 ± 7.2 | 0.41 * | −0.06 | −0.35 | −0.06 | −0.23 | −0.12 | 0.12 | −0.04 |
IL‐10 | 4.2 ± 2.2 | −0.09 | −0.23 | −0.18 | −0.31 | −0.17 | −0.21 | −0.18 | −0.27 |
IL‐27 | 196 ± 68 | −0.34 | −0.13 | 0.04 | −0.25 | 0.18 | 0.07 | 0.06 | −0.11 |
VEGF | 94 ± 35 | 0.01 | −0.01 | −0.02 | 0.12 | 0.41 * | 0.12 | 0.48 * | 0.10 |
IFN‐γ | 36 ± 19 | 0.12 | −0.18 | −0.15 | −0.16 | −0.26 | −0.17 | −0.24 | −0.20 |
IL‐31 | 62 ± 31 | −0.15 | −0.06 | 0.11 | 0.03 | −0.26 | 0.00 | 0.00 | −0.07 |
IL‐1α | 9.4 ± 4.1 | 0.06 | −0.29 | −0.26 | −0.19 | −0.31 | −0.16 | −0.20 | −0.27 |
IL‐4 | 102 ± 30 | 0.06 | −0.28 | −0.19 | −0.17 | −0.30 | −0.17 | 0.18 | −0.25 |
IL‐17 | 4.9 ± 1.3 | −0.33 | −0.38 | −0.14 | −0.19 | −0.14 | −0.25 | 0.00 | −0.35 |
BAFF | 920 ± 269 | 0.14 | −0.17 | −0.13 | −0.12 | −0.22 | −0.10 | −0.18 | −0.15 |
IL‐13 | 354 ± 106 | 0.01 | −0.06 | −0.02 | −0.19 | 0.21 | 0.05 | 0.36 | −0.06 |
IFN‐α | 3.3 ± 1.0 | 0.11 | 0.04 | 0.16 | 0.20 | −0.09 | 0.21 | −0.02 | 0.11 |
IL‐23 | 413 ± 166 | 0.07 | −0.29 | −0.19 | −0.27 | −0.18 | −0.25 | −0.09 | −0.26 |
Note: Boldface letters mean statistically significant.
Abbreviations: BAFF, B‐cell activating factor belonging to the tumor necrosis factor family; GIT, gastrointestinal tract; IFN, interferon; IL, interleukin; TNF‐α, tumor necrosis factor‐alpha; VEGF, vascular endothelial growth factor.
P < 0.05.